XIST and non-small cell lung carcinoma: Additionally, Wang et al. (2017b) showed that suppression of XIST inhibited cell growth and invasion, and induced apoptosis through reciprocal inhibition of miR-186-5p, which could be a new therapeutic biomarker in NSCLC.